Pharmstandard Slumps Most in Week as Buyback Ends: Moscow Mover

OAO Pharmstandard fell the most in a week after Russia’s biggest pharmaceutical company completed a $247 million share buyback.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.